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Background: Although several studies have reported an association between mental disorders and serum levels of
brain-derived neurotrophic factor (BDNF), this association is still poorly understood. The study of factors associated
with both BDNF levels and mental disorders, such as n-3 polyunsaturated fatty acids (n-3 PUFAs), may help to
elucidate the mechanisms mediating the relationship between the two variables. Therefore, the present study
aimed to evaluate whether the intake n-3 PUFAs correlates with serum levels of BDNF.
Findings: This study involved 137 adolescents drawn from a community sample, including a group with high levels
of anxiety, assessed using the Screen for Children and Anxiety Related Emotional Disorders. Blood samples were
collected and serum BDNF levels were measured. n-3 PUFAs were estimated using a food frequency questionnaire
for adolescents. Correlations were performed to assess the association between n-3 PUFAs intake and BDNF levels.
Effects of potential confounders (total fat consumption, age, gender and anxiety) were examined using linear
regression models. There was a direct correlation between n-3 PUFAs consumption and serum BDNF levels, which
remained significant even after accounting for potential confounders.
Conclusions: We were able to detect a correlation between n-3 PUFAs intake and peripheral BDNF levels. Our
study was limited by its small sample size, and our external validity may be restricted by the oversampling of
anxious adolescents. Our findings may help determine the nature of the association between mental disorders
and serum levels of BDNF. However, more studies are needed to elucidate the possible mechanisms by which n-3
PUFAs intake affects BDNF levels, and how this may lead to an increased vulnerability to psychiatric disorders.
Keywords: Anxiety, Children, Adolescents, SCARED, BDNFBackground
Brain-Derived Neurotrophic Factor (BDNF) is a dimeric
protein thought to be involved in neuronal survival and
synaptic plasticity, and to be an important biomarker for
psychiatric conditions such as depression and bipolar dis-
order [1-3]. It is a member of the growth factor family and
acts as a regulator of synaptic plasticity, synaptogenesis, as
well as neuronal survival and differentiation [4-6]. There-
fore, the understanding of processes associated with both* Correspondence: neurocientista@hotmail.com
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unless otherwise stated.BDNF levels and mental disorders may ultimately help de-
termine the underlying mechanisms responsible for the
association between these two variables.
Studies of human subjects have demonstrated that lower
per capita fish/seafood consumption, which can be used
as a surrogate measurement of n-3 polyunsaturated fatty
acids (PUFAs) dietary intake, is associated with a higher
prevalence of bipolar spectrum disorders [7,8], major de-
pression [9,10] and postpartum depression [11,12]. Experi-
mental studies in rats demonstrate that polyunsaturated
fatty acids (PUFAs) could modify brain BDNF levels
[13-15] and may play an important role in the function
and structure of many membrane proteins [16,17]. Never-
theless, there is still a need to investigate whether theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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translates to humans. In light of these above findings, the
aim of the present study was to evaluate whether the con-
sumption of n-3 PUFAs correlates with serum BDNF
levels in humans.Findings
The current study involved 137 adolescents drawn from a
community sample, including a group with high rates of
anxiety (64.6% female; mean age 13.9 years, SD = 2.42), as
assessed by the Screen for Children and Anxiety Related
Emotional Disorders (SCARED) [18]. A detailed descrip-
tion of the sampling process can be found elsewhere [19].
Briefly, all quartiles of the distribution of SCARED scores
were equally represented in the sample (i.e., no to very
low anxiety, mild anxiety, moderate anxiety and severe
anxiety), although there was an oversampling of partici-
pants in the upper quartile (severe anxiety). The SCARED
inventory comprises 38 items that can be grouped into
subscales according to the different anxiety symptoms in-
vestigated, and consists of a screening tool for DMS-IV
childhood anxiety disorder. The present study was ap-
proved by the Research Ethics Committee of the Hospital
de Clínicas de Porto Alegre (GPPG/HCPA, protocol
number 08–481). Informed consent was provided by allFigure 1 Correlation between n-3 polyunsaturated fatty acids (n-3 PUF
neurotrophic factor (BDNF). The correlation between n-3 PUFAs intake anprimary caretakers, and all adolescents assented to partici-
pate in the study.
Blood samples were collected between 7 and 10 am after
a fasting period of 10–12 hours, centrifuged for 5 minutes
at 4500 rpm, and serum was stored at −80°C in order to
measure BDNF levels. All BDNF measurements were
performed on the same day by sandwich-ELISA using
monoclonal antibodies specific for BDNF (R&D Systems,
Minneapolis, Minnesota), according to the manufacturer’s
instructions. The intra-assay and inter-assay coefficients of
variation were 3.7 and 8.5%, respectively. n-3 PUFAs
intake was estimated by a food frequency questionnaire
administered to the adolescents (FFQ) [20]. The quan-
titative analysis of macro and micronutrient intake was
performed using the NutriBase® software (Version NB7
Network) [Phoenix, AZ, USD]. Spearman correlations
were performed to assess the association between n-3
PUFA intake and BDNF levels. The effects of potential
confounders (total fat intake, age, gender and symptoms
of anxiety) were examined using linear regression models
(involving log-transformed BDNF values, logBDNF).
The correlation between n-3 PUFA intake and BDNF
levels was statistically significant, rs = 0.172, p = 0.043
(Figure 1). Multivariate linear regression models showed
that even after controlling for the confounders, n-3 PUFA
intake was associated with higher levels of logBDNFAs) intake (g/day) and peripheral levels (ng/mL) of brain-derived
d BDNF levels was statistically significant (rs = 0.172, p = 0.043).
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rity was found in the model.
Discussion
We were able to show that n-3 PUFAs intake is asso-
ciated with serum BDNF levels in adolescents, corrobo-
rating to the suggestion that the relationship between
mental disorders and BDNF may be mediated by the in-
take of nutrients such as n-3 PUFAs. This may influence
the cellular and physiological processes involved in
psychiatric/mood disorders, such as the fatty acid com-
position of cellular membranes, the modulation of
behavioral systems, neurodevelopment, and oxidative
stress in specific brain areas [21-25].
Studies suggest that n-3 PUFA-depleted rodents ex-
hibit changes in emotional status such as elevated ag-
gression, depression and anxiety [26-31]. Moreover, the
dietary deprivation of n-3 PUFAs in rats may lead to
changes in the expression of BDNF in the frontal cortex,
in cAMP response element binding protein (CREB) ac-
tivity and reduce p38 mitogen-activated protein kinase
(MAPK) activity [13].
It is noteworthy that the food frequency questionnaire
used in the study contained a varied list of 94 foods or
drinks [20,32]. Thus, the corresponding food sources to
the n-3 PUFAs consumption among students were di-
verse, including vegetable oils and products/preparations
based in oils (e.g. biscuits, mayonnaise and fried foods),
according to calculations performed with the values
depicted in the American Food Table [33]. Besides fish
and oils consumption, red meat is also considered a
source of n-3 PUFAs [34], and our region is especially
known to have a high consumption of meat. A national
survey conducted in both urban and rural areas through-
out the country with analysis of individual food consump-
tion in Brazil from 2008–2009 [35], reported that the
Southern region of Brazil, including the State of Rio
Grande do Sul, where the city Porto Alegre lays, was iden-
tified as one of the leading regions in the consumption of
red or pork meat. Besides, it was also observed that among
10 to 13 years old population, the n-3 PUFAs displayed a
high daily consumption (mean: 1.5 g) in this region, com-
pared to other Brazilian regions. Meat intake is tradi-
tionally high and typical from our region, which could
probably corroborate to the high n-3 PUFAs consumption
levels evidenced in this study.
It is important to note that our study is limited by its
small sample size, and that the oversampling of anxious
adolescents may restrict our external validity. However, in
spite of these limitations, we were able to detect a cor-
relation between n-3 PUFAs consumption and serum
BDNF levels. The extent to which peripheral BDNF levels
are representative of central nervous system BDNF levels
remains to be investigated, although positive correlationsbetween serum and cortical BDNF levels have been re-
ported in preclinical studies [36], and cellular and beha-
vioral brain functions have been found to be modulated by
peripheral BDNF [37]. Furthermore, serum BDNF levels
have been associated with neuronal integrity in healthy
subjects [38] and decreased BDNF peripheral levels (i.e.
serum or plasma) have been consistently found in patients
with mood disorders [39,40]. BDNF is implicated in a
variety of neural processes and is related to neuronal de-
velopmental stages in both animals and humans [39].
Lang, Hellweg, Sseifert, Schubert and Gallinat, 2007 [38]
reported that serum BDNF protein concentrarion might
reflect some aspects of neuronal plasticity in the living hu-
man brain, playing a role as regulators of neuronal survival
and differentiation. Similar findings have been reported by
Poo, 2001 [6]. Recent studies demonstrate that decreased
peripheral BDNF levels are consistently related to disease
activity and progression in bipolar disorder [41] as well as
to the cognitive impairment seen in patients following
their first psychotic episode [42]. More studies are needed
to elucidate the possible mechanisms by which n-3 PUFAs
consumption affects BDNF levels and influences the
vulnerability to psychiatric and mood disorders, especially
during certain life stages such as adolescence.
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